GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Respiratorius AB (XSAT:RESP) » Definitions » Common Stock

Respiratorius AB (XSAT:RESP) Common Stock : kr15.30 Mil (As of Dec. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Respiratorius AB Common Stock?

Respiratorius AB's quarterly common stock increased from Jun. 2024 (kr14.62 Mil) to Sep. 2024 (kr25.49 Mil) but then declined from Sep. 2024 (kr25.49 Mil) to Dec. 2024 (kr15.30 Mil).

Respiratorius AB's annual common stock stayed the same from Dec. 2022 (kr14.62 Mil) to Dec. 2023 (kr14.62 Mil) but then increased from Dec. 2023 (kr14.62 Mil) to Dec. 2024 (kr15.30 Mil).


Respiratorius AB Common Stock Historical Data

The historical data trend for Respiratorius AB's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Respiratorius AB Common Stock Chart

Respiratorius AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.43 10.69 14.62 14.62 15.30

Respiratorius AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Apr22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.62 14.62 14.62 25.49 15.30

Respiratorius AB Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Respiratorius AB Business Description

Traded in Other Exchanges
N/A
Address
Scheelevagen 2, Medicon Village, Lund, SWE, 223 81
Respiratorius AB develops pharmaceutical drugs to treat the common diseases namely Cancer, Chronic Obstructive Pulmonary Disease (COPD), and asthma as well as better methods for diagnosing cardiovascular diseases. The company's drug candidates includes RCD405, VAL001, RESP2000, RESP3000, RESP9000, and RESP1000.

Respiratorius AB Headlines

No Headlines